![]() ![]() Digestive: Abnormal liver function tests. Do not rub site post injection.Īdverse Effects ( 1%) Body as a Whole: Allergic reactions (rash, urticaria), fever, angioedema arthralgia, pain and inflammation at injection site, peripheral edema, arthralgia, fever. Hold the skin fold between the thumb and forefinger and insert the whole length of the needle into the skin fold.Alternate injections between left and right anterolateral and posterolateral abdominal wall.Place patient in a supine position for injection of the drug.Do not expel the air bubble from the 30 or 40 mg prefilled syringe before injection.Use a TB syringe or prefilled syringe to ensure accurate dosage.starting 2 h before surgery and continuing for 7≡0 d (max: 12 d)Īdult: SC 1 mg/kg q12h or 1.5 mg/kg/d monitor anti-Xa activity to determine appropriate doseĪdult: SC 1 mg/kg q12h for 2≨ d, give concurrently with aspirin 100≣25 mg/d Prevention of DVT after Abdominal SurgeryĪdult: SC 40 mg q.d. Route & Dosage Prevention of DVT after Hip or Knee SurgeryĪdult: SC 30 mg b.i.d. Safety and effectiveness in children are not established. Puncture, menstruation, obesity, peptic ulcer disease, older adults, endocarditis, renal disease, renal impairment, spinalĪnesthesia, stroke, surgery, pregnancy (category B), lactation. Increased risk of bleeding, hepatic disease, hypertension, coagulopathy, thrombolytic therapy, thrombocytopenia, dental disease,ĭental work, diabetic retinopathy, dialysis, diverticulitis, inflammatory bowel disease, intramuscular injections, lumbar Uncontrolled arterial hypertension, recent history of GI disease, benzyl alcohol hypersensitivity, conditions or surgery with Purpura (ITP), hypersensitivity to enoxaparin porcine protein hypersensitivity, neonates. Thrombocytopenia associated with an antiplatelet antibody in the presence of enoxaparin, bleeding disorders, idiopathic thrombocytopenia ![]() Patients with active major bleeding, GI bleeding, hemophilia, heparin hypersensitivity, heparin-induced thrombocytopenia (HIT), Prevention of deep vein thrombosis (DVT) after hip, knee, or abdominal surgery, treatment of DVT and pulmonary embolism, management AnĮffective anticoagulation agent used for prophylactic treatment as an antithrombotic agent following certain types of surgery. Thromboplastin time (aPTT) up to 1.8 times the control value.Īntithrombotic properties are due to its antifactor Xa and antithrombin (antifactor IIa) in the coagulation activities. Does affect thrombin time (TT) and activated Low molecular weight heparin with antithrombotic properties. Classifications: blood formers, coagulators, and anticoagulants low molecular weight heparinģ0 mg/0.3 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg/1 mL injection Actions ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |